Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system
- PMID: 32961274
- PMCID: PMC7501874
- DOI: 10.1016/j.micinf.2020.09.004
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system
Abstract
This article discusses standard and new disruptive strategies in the race to develop an anti-COVID-19 vaccine. We also included new bioinformatic data from our group mapping immunodominant epitopes and structural analysis of the spike protein. Another innovative approach reviewed here is the use of BCG vaccine as priming strategy and/or delivery system expressing SARS-CoV-2 antigens.
Keywords: BCG; COVID-19; RBD domain; SARS-CoV-2; Vaccines.
Copyright © 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Conflict of interest statement
Declaration of competing interest EJH is an employee and equity holder in ioGenetics LLC. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures




References
-
- WHO Summary of MERS cases with onset of illness from 1 September 2012. https://www.who.int/emergencies/mers-cov/en/ Available at:
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous